Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea
NCT00989014
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Erythematotelangiectatic Rosacea
Interventions
DRUG:
CD07805/47
DRUG:
CD07805/47
DRUG:
CD07805/47
DRUG:
CD07805/47 placebo
Sponsor
Galderma R&D